BIOMARIN PHARMABIOMARIN PHARMABIOMARIN PHARMA

BIOMARIN PHARMA

No trades
See on Supercharts

Price target

100.480.00 0.00%
The 25 analysts offering 1 year price forecasts for BM8 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 30 analysts giving stock ratings to BM8 in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

BM8 EPS for the last quarter is 0.41 CHF despite the estimation of 0.28 CHF. In the next quarter EPS is expected to reach 0.31 CHF. Track more of BIOMARIN PHARMA financials and stay on top of what is up with the company.
In the next quarter BIOMARIN PHARMA revenue is expected to reach ‪603.73 M‬ CHF. Check out BIOMARIN PHARMA revenue and earnings and make informed decisions.
According to analysts, BM8 price target is 100.48 CHF with a max estimate of 127.85 CHF and a min estimate of 73.06 CHF. Check if this forecast comes true in a year, meanwhile keep track of the current situation with BM8 news and stock market news.
We've gathered opinions of 30 analysts rating BM8 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.